Jeffrey W. Moses, MD

A Multicenter, Randomized, Dose-Finding Study of Gamma Intracoronary Radiation Therapy to Inhibit Recurrent Restenosis after Ste

08/01/2008

Roberto Lipsztein , MD;

Prabhakar Tripuraneni , MD;

Paul S. Teirstein , MD, FACC;

Martin B. Leon , MD;

Alexandra J. Lansky , MD;

Manuela Negoita , MD;

Huan Giap , MD;

Ray Lin , MD;

Stephen Balter , PhD;

Roxana Mehran , MD;

Shirish Jani , PhD;

Matthew J. Price , MD;

Jeffrey W. Moses , MD;

Stephen Steuterman , MS;

Michael B. Collins , MD;

Jack Dalton , MD;

Intracoronary radiation therapy (ICRT) for in-stent restenosis within bare metal stents substantially reduces the risk of recurrence.1–3 However, target vessel failure remains a significant clinical problem for some patients. A higher...

Intracoronary radiation therapy...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Impact of Surgical Consultation on Outcomes in Hemodynamically Supported High-Risk Percutaneous Coronary Intervention: Insights From PROTECT II Randomized Study

02/15/2016

Ray V. Matthews , MD;

David M. Shavelle , MD, FACC, FSCAI;

William W. O'Neill , MD;

Jeffrey W. Moses , MD;

Ajay J. Kirtane , MD, SM;

Jeffrey J. Popma , MD, FACC, FSCAI;

Neel K. Kapasi , MD;

Theodore L. Schreiber , MD;

An investigation on whether the use of hemodynamic support during PCI can mitigate the adverse prognostic importance of surgical ineligibility.

An investigation on whether the...

02/15/2016

Journal of Invasive Cardiology

Case Report

Percutaneous Coronary Intervention in a Sequential Radial Artery Graft Anastomosed to <br />
the Descending Aorta, Left Circumflex Ar

08/01/2008

Jeffrey W. Moses , MD;

Yoshio Kobayashi , MD;

Nadim Al-Mubarak , MD;

Poor long-term patency rates have been documented for saphenous vein grafts; only 50–60% of saphenous vein grafts are patent 10 years post-operation.1 On the other hand, excellent long-term patency of the left internal mammary artery for...

Poor long-term patency rates...

08/01/2008

Journal of Invasive Cardiology

Clinical Editor's Corner

Conversations in Cardiology: Is There Value in Post-PCI Troponin Measurements?

01/03/2023

Duane S. Pinto , MD, MPH;

Timothy D. Henry , MD;

Neal S. Kleiman , MD;

Samuel M. Butman , MD;

David G. Rizik , MD, FACC, FSCAI;

Gurpreet S. Sandhu , MD, PhD;

Bonnie H. Weiner , MD, MBA, FSCAI, FACC;

Rajiv Gulati , MD, PhD;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Kirk N. Garratt , MD, MSc;

Dean J. Kereiakes , MD, FACC, FSCAI;

Jeffrey W. Moses , MD;

Srihari S. Naidu , MD;

Peter L. Duffy , MD, MMM, FACC, FSCAI;

Christopher J. White , DO, MD;

Ajay J. Kirtane , MD, SM;

If we don’t make changes in patient care after PCI regardless of the troponin level, is there any value in ordering it?

If we don’t make changes in...

01/03/2023

Cath Lab Digest

Clinical Editor's Corner

A Relook at the Transseptal Puncture: Heparin Dosing and Other Top Tips

11/05/2017

Jeffrey W. Moses , MD;

Zoltan G. Turi , MD;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Jonathan M. Tobis , MD;

Matthew J. Price , MD;

Chet Rihal ;

Given the infrequency with which we perform TSP, I asked my expert cath lab colleagues about the need for more heparin in TSP for only diagnostic purposes. In addition, I also asked, “Does the anticoagulation regimen differ for each type of...

Given the infrequency with which...

11/05/2017

Cath Lab Digest

Frequency and Determinants of ‚ÄúBlack Holes‚Äù in Sirolimus-Eluting Stent Restenosis

08/01/2008

Stephane G. Carlier , MD, PhD;

Jeffrey W. Moses , MD;

Jose de Ribamar Costa Jr., MD, PhD;

Masashi Kimura , MD, PhD;

Kenichi Fujii , MD;

Kaoru Tanaka , MD, PhD;

Joanna Lui , BA, MD;

Gary S. Mintz , MD;

Martin B. Leon , MD;

Koichi Sano , MD, PhD;

In-stent restenosis is the result of neointimal hyperplasia that, by intravascular ultrasound (IVUS) imaging, typically has a homogeneous, echoreflective appearance. Histological and immunohistochemical analyses of “typical” in-stent...

In-stent restenosis is the...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Contrast Utilization During Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry

07/01/2016

William L. Lombardi , MD;

Mitul P. Patel , MD;

Santiago Garcia , MD;

Khaldoon Alaswad , MD;

Georgios Christopoulos , MD;

Dimitrios Karmpaliotis , MD, PhD;

Farouc A. Jaffer , MD, PhD;

Robert W. Yeh , MD, MBA, MSc;

John N. Bahadorani , MD;

Matthew T. Finn , MD, MS;

Michael R. Wyman , MD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

J. Aaron Grantham , MD;

Jeffrey W. Moses , MD;

Subhash Banerjee , MD, FSCAI;

Nicholas J. Lembo , MD;

Phillip Green , MD;

David E. Kandzari , MD;

Anthony H. Doing , MD;

Manish A. Parikh , MD;

Craig A. Thompson , MD, MMSc;

Aris Karatasakis , MD;

Georgios E. Christakopoulos , MD;

Ajay J. Kirtane , MD, SM;

This study examines the association of clinical, angiographic, and procedural variables with contrast volume administered during 1330 CTO-PCIs performed at 12 experienced United States centers.

This study examines the...

07/01/2016

Journal of Invasive Cardiology

Case Report

Cutting Balloon Angioplasty for Underexpanded Stent Deployed Through Struts of Previously Implanted Stent

08/01/2008

Octavia Balan , MD;

Jeffrey W. Moses , MD;

Yoshio Kobayashi , MD;

Since randomized studies showed a lower restenosis rate in focal coronary artery lesions with coronary stenting compared to conventional balloon angioplasty,1 indications for stenting expanded to complex lesions such as bifurcation and...

Since randomized studies showed...

08/01/2008

Journal of Invasive Cardiology

Clinical Editor's Corner

Should We Do Elective Cardiac Catheterizations on the Weekends?

03/02/2022

Samuel M. Butman , MD;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Chet Rihal ;

Jeffrey W. Moses , MD;

Steven R. Bailey , MD;

Gurpreet S. Sandhu , MD, PhD;

Srihari S. Naidu , MD;

Frederick G.P. Welt , MD;

Kirk N. Garrett ;

Barry F. Uretsky , MD;

Lloyd W. Klein , MD;

Carl L. Tommaso , MD;

Gregg W. Stone , MD, FACC, FSCAI;

Richard Chazal , MD;

Duane S. Pinto , MD, MPH;

Rajiv Gulati , MD, PhD;

James C. Blankenship , MD;

David G. Rizik , MD, FACC, FSCAI;

Bonnie H. Weiner , MD, MBA, FSCAI, FACC;

The issue of working weekends to deliver more care is complex and requires a thoughtful game plan to commit the resources for the value of the expanded services. In the times of COVID, the need for hospital throughput has never been more...

The issue of working weekends to...

03/02/2022

Cath Lab Digest

Clinical Editor's Corner

Conversations in Cardiology – Does Every Primary PCI Lab Need an Impella* (or Its Equivalent)?

07/26/2016

Aaron V. Kaplan ;

Lloyd W. Klein , MD;

Gurpreet S. Sandhu , MD, PhD;

Gregg W. Stone , MD, FACC, FSCAI;

Peter B. Berger , MD;

David E. Kandzari , MD;

George W. Vetrovec , MD;

Ted Feldman , MD, FSCAI, FACC, FESC;

Jim Blankenship , MD;

Navin Kumar Kapur , MD;

Bonnie H. Weiner , MD, MBA, FSCAI, FACC;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Christopher J. White , DO, MD;

Jeffrey W. Moses , MD;

Ajay J. Kirtane , MD, SM;

Steven R. Bailey , MD;

In this “Conversation in Cardiology”, Dr. Ted Feldman from Evanston Hospital, Evanston, Illinois, asks, “Is the availability of Impella a requirement for every STEMI [ST-elevation myocardial infarction] program (even in lower volume programs...

In this “Conversation in...

07/26/2016

Cath Lab Digest